Inept management, could not even ensure Gi Guard trial by ensuring the new inferior product could not even be kept at a controlled temperature.
The switched to a new product that required all new trials be performed ensuring more costs and delays. Or is that shareholders hanging on in anticipation, whilst the coy can ensure its existence and support with further dreams.
Management and associates are not what I would deam a good investment. Back to the kennel for this one.
BPO Price at posting:
0.5¢ Sentiment: Sell Disclosure: Not Held
